The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma.
Journal
The Lancet. Haematology
ISSN: 2352-3026
Titre abrégé: Lancet Haematol
Pays: England
ID NLM: 101643584
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
26
05
2020
revised:
12
10
2020
accepted:
02
11
2020
pubmed:
29
12
2020
medline:
5
1
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
This Review focuses on the use of
Identifiants
pubmed: 33357487
pii: S2352-3026(20)30365-3
doi: 10.1016/S2352-3026(20)30365-3
pii:
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e80-e93Subventions
Organisme : Department of Health
ID : RP-2016-07-001
Pays : United Kingdom
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.